Whittier Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-4,436
Closed -$88K 1678
2022
Q2
$88K Buy
4,436
+1,425
+47% +$37.9K ﹤0.01% 824
2022
Q1
$95K Buy
+3,011
New +$84.4K ﹤0.01% 831

Other funds holding CLB

Whittier Trust's CLB Position: Q3 2022 in Review

Whittier Trust sold out of Core Laboratories (CLB) in Q3 2022, closing a stake of 4,436 shares — an estimated $88K sold.

Whittier Trust first reported a position in CLB in Q1 2022 and held it in 2 quarters. The position peaked at $95K in Q1 2022. 162 funds tracked by Wall St. Rank hold CLB as of Q3 2022.

  • Whittier Trust reported no remaining Core Laboratories position as of Q3 2022 after selling out during the quarter.
  • Whittier Trust sold 4,436 Core Laboratories shares in Q3 2022, an estimated $88K.
  • Whittier Trust first reported a position in Core Laboratories in Q1 2022 and held it in 2 quarters.
  • Whittier Trust's Core Laboratories position peaked at $95K in Q1 2022.
  • 162 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2022.

Based on Whittier Trust's 13F filing for Q3 2022, filed 21 Oct 2022.